Protesting Adcock Ingram workers have Cyril Ramaphosa in their sights

Interim net profit nearly doubled, and it declared a 16% increase in its dividend, after leaving a market that, in contrast to SA, is suffering waning demand

The departure provides a further opportunity for GlaxoSmithKline CEO Emma Walmsley to stamp her imprint on Britain’s biggest drug maker

The Japanese firm plans to keep its headquarters in Osaka and may reduce the combined workforce by up to 7%

New facility to produce specialised medicines for chronic conditions

About 95% of the new products will be exported to Latin America, Europe, Asia and Africa, with Europe having been the first to give its regulatory approval

Dis-Chem chief financial officer Rui Morais talks to Business Day TV about the company’s full-year results

The Danish drug maker, the world’s biggest insulin supplier with 46% of the market, has increased its sales forecast

The hospital group says it expects to report that its basic earnings more than quadrupled in the six months to end-March

Things are looking better in the Middle East for the private healthcare group, though margins in Switzerland are being squeezed

Local vaccine manufacture brought in to try to improve security of supply for SA and the region

CEO Dr Shrey Viranna talks to Business Day TV about the company’s business strategy

SA’s new medicines regulator, Sahpra, needs to overhaul its fee structure

Netcare had done the right thing when it invested in the UK, but the market had changed dramatically since then, says CEO Richard Friedland

The group’s financial position remains sound, with strong cash generation

The deal goes through on condition that the new owners do not hike fees immediately

The state-owned pharmaceutical company invites partners to help it supply essential medicines to South Africa and the region